| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |